Viimane versioon :
08/05/2024
Infostab
Ingredientide nimekiri
Nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
Uurimisrühmad
Valistab
Plakat
Sidemed
Sponsorid
Autor
Kasutusjuhend
Ajakiri
Morphine tartrate
Keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Morphine tartrate
Austraalia
Viited : Morphine tartrate
Tüüp
Avaldamine
519
Ajaleht
Poggi GL.
Compatibility of morphine tartrate admixtures in polypropylene syringes.
Aust J Hosp Pharm 1991 ; 21: 316.
920
Ajaleht
Targett PL, Keefe PA, Merridew CG.
Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes.
Aust J Hosp Pharm 1997 ; 27: 452-454.
980
Ajaleht
Ambados F.
Compatibility of morphine and ketamine for subcutaneous infusion.
Aust J Hosp Pharm 1995 ; 25: 352.
1864
Ajaleht
Lau MH, Hackman C, Morgan DJ.
Compatibility of ketamine and morphin injections.
Pain 1998 ; 75: 389-390.
2083
Ajaleht
La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
J Pharm Pract and Res 2002 ; 32: 65-68.
3474
Labor
Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3504
Labor
Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012
3644
Labor
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3675
Labor
Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015
3838
Labor
Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
3934
Labor
Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
GlaxoSmithKline Laboratoire 2016
Mentions Légales
